Fenspiride Hydrochloride Catalog No.:M8233-10 It reduces antigen-induced histamine release

It reduces antigen-induced histamine release from rat conjunctival tissue by 46% in vitro when used at a concentration of 10 µg/ml

The responses of 6 PDAC cell lines in regards to FAK Y397 phosphorylation or activity to GSK2256098 treatments (0

Nurmemmedov E

resulting in receptor activation

Neurogastroenterol Motil

Fenspiride Hydrochloride Catalog No.:M8233-10 It reduces antigen-induced histamine releaseFenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases. The pharmacotherapeutic classification is antitussives. In Russia it is approved for the treatment of acute and chronic inflammatory diseases of ENT organs (ear, nose, throat) and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis), as well as for maintenance treatment of asthma. Product